NDC 0469-1230 – Prograf
Tacrolimus .2 mg/1 · Granule, For Suspension · Oral
Product NDC0469-1230
Product details
- Brand name
- Prograf
- Generic name
- Tacrolimus
- Labeler
- Astellas Pharma US, Inc.
- Dosage form
- Granule, For Suspension
- Route
- Oral
- Marketing category
- NDA · NDA210115
- Marketed since
- May 24, 2018
- Listing expires
- December 31, 2026
- Pharmacologic class
- Calcineurin Inhibitor Immunosuppressant
Active ingredients
- Tacrolimus .2 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0469-1230-50 | 50 PACKET in 1 CARTON (0469-1230-50) / 1 GRANULE, FOR SUSPENSION in 1 PACKET | May 24, 2018 |
Recalls mentioning this NDC
- D-0211-2025 Feb 5, 2025 · Class I
Failed Tablet/Capsule Specifications: Bottles shipped to the USA may contain empty capsules
Other Prograf products
- 0469-1330 Tacrolimus 1 mg/1 · Granule, For Suspension · Astellas Pharma US, Inc.
- 0469-0607 Tacrolimus .5 mg/1 · Capsule, Gelatin Coated · Astellas Pharma US, Inc.
- 0469-0617 Tacrolimus 1 mg/1 · Capsule, Gelatin Coated · Astellas Pharma US, Inc.
- 0469-0657 Tacrolimus 5 mg/1 · Capsule, Gelatin Coated · Astellas Pharma US, Inc.
- 0469-3016 Tacrolimus 5 mg/mL · Injection, Solution · Astellas Pharma US, Inc.